Article snapshot taken from Wikipedia with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, Missouri. The company was founded on March 16, 1981, by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries. The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ. The primary therapeutic compounds marketed by the company include Thrombin-JMI and Levoxyl. On May 30, 2000, the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, Tennessee. The market value of the company on its closing trade was $3.6 billion. Parent company King Pharmaceuticals was acquired by Pfizer in 2010.
King Pharmaceuticals merging with Jones Pharma in $3.4 Billion Deal thepharmaletter.com
St. Louis Business Journal: He's a multimillionaire who never went to college, yet within 20 years built Jones Pharma into a business that was acquired for $3.4 billion
Read more: Dennis Jones - St. Louis Business Journal